Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 18.19B | 18.07B | 17.36B | 17.33B | 16.68B | 15.43B |
Gross Profit | 3.61B | 3.64B | 3.54B | 3.47B | 3.31B | 2.98B |
EBITDA | 1.77B | 1.84B | 1.76B | 1.88B | 1.77B | 1.41B |
Net Income | 1.25B | 1.29B | 1.18B | 1.29B | 1.21B | 937.00M |
Balance Sheet | ||||||
Total Assets | 14.10B | 14.43B | 13.59B | 12.88B | 12.26B | 11.22B |
Cash, Cash Equivalents and Short-Term Investments | 9.62B | 9.47B | 9.85B | 8.47B | 7.39B | 6.36B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 2.43B | 2.65B | 2.65B | 2.56B | 2.75B | 2.60B |
Stockholders Equity | 11.66B | 11.78B | 10.94B | 10.31B | 9.51B | 8.62B |
Cash Flow | ||||||
Free Cash Flow | 1.25B | 739.00M | 1.39B | 1.58B | 902.00M | 1.04B |
Operating Cash Flow | 1.29B | 766.00M | 1.39B | 1.58B | 948.00M | 1.08B |
Investing Cash Flow | -54.00M | -32.00M | 23.00M | 15.00M | -76.00M | -38.00M |
Financing Cash Flow | -523.00M | -510.00M | -640.00M | -507.00M | -347.00M | -437.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥14.30B | 9.81 | 3.60% | 10.61% | 102.16% | ||
84 Outperform | ¥13.62B | 14.47 | 3.60% | 2.47% | 46.51% | ||
79 Outperform | ¥14.13B | 11.31 | 3.70% | 4.86% | 4.48% | ||
68 Neutral | ¥13.86B | 19.28 | 3.62% | -1.03% | -3.19% | ||
61 Neutral | $35.55B | 8.88 | -11.02% | 1.87% | 8.55% | -8.14% | |
60 Neutral | ¥19.41B | 8.79 | 0.29% | -40.21% | -54.31% | ||
40 Neutral | ¥8.02B | ― | ― | 99.79% | 7.36% |
HIMACS, Ltd. has reported its consolidated financial results for the nine months ending December 31, 2024, showing a year-on-year increase in net sales by 2.5% reaching 13,326 million yen, and a significant rise in profits attributable to owners of the parent by 10.2%. The company’s financial position remains strong with an equity ratio of 82.0%. The forecast for the full fiscal year ending March 31, 2025, predicts continued growth with net sales expected to increase by 7.2%, indicating a positive outlook for the company’s stakeholders.